Tscan therapeutics announces publication in cell highlighting the discovery of tumor antigens and tcrs for the treatment of solid tumors using foundational screening technology

Tscan screening technology used to identify the targets of expanded t cell clones in the tumors of patients with head and neck cancer responding to neoadjuvant immunotherapy

TCRX Ratings Summary

TCRX Quant Ranking